Ban on hunting for new viruses in wildlife is at odds with program’s mission, researchers say
Biotech executive Steven Quay may be in contention for leadership role in infectious disease institute
Companies striving to reduce continent’s reliance on foreign shots must overcome major financial and logistical challenges
David Morens awaits sentencing after admitting to trying to avoid Freedom of Information Act requests
Researchers who study HIV, tuberculosis, and other infectious disease in the country welcome policy change
Trial failed of supposedly potent antibodies that the leading vaccine candidates aim to trigger
Gilead is criticized for lack of affordable access to lenacapavir in Latin America
One shot of lenacapavir can protect for 6 months—but aid cuts and uncertain demand mean little drug has reached the countries that most need it
Specific class of immune cells help keep virus at bay for months or years—even in the absence of drugs
Specific class of immune cells help keep virus at bay for months or years—even in the absence of drugs
A retreat from investments in drugs and vaccines leaves U.S. less prepared for the next viral scourge, experts warn
A retreat from investments in drugs and vaccines leaves U.S. less prepared for the next viral scourge, experts warn